Sterile Injectable Drugs Market Segmentation by Type (Small Molecule, and Large Molecule); by Drug Class (Insulin, Hormones, Vaccines, Peptide Antibiotic, Cytokines, and Others); by Application (Pain, Infections, Autoimmune Disease, Diabetes, Cardiovascular Diseases, and Others); and by Distribution Channel (Hospitals, Pharmacy, Ambulatory Surgical Centers, and Others)– Global Demand Analysis & Opportunity Outlook 2029

Buy Now Report ID: 3050 | Published Date: Feb 10, 2023

Global Sterile Injectable Drugs Market Regional Synopsis

Regionally, the global sterile injectable drugs market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America region is estimated to witness largest share over the forecast period on the back of high investment in healthcare sector, along with increasing medical R&D activities in the region. According to the data by the World Bank, per capita healthcare expenditure in the North America amounted to USD 10,050.279, in 2018. The market in the Asia Pacific is estimated to witness a noteworthy growth during the forecast period, owing to the improving healthcare sector backed by rising disposable income and economic development in the region.

Global Sterile Injectable Drugs Market

The global sterile injectable drugs market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis.
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Sterile Injectable Drugs Market
Get more information on this report: Request Free Sample PDF

Major Macro-Economic Indicators Impacting the Market Growth

Healthcare Expenditure

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Market Segmentation


Our in-depth analysis of the global sterile injectable drugs market includes the following segments:

By Type

  • Small Molecule
  • Large Molecule

By Drug Class

  • Insulin
  • Hormones
  • Vaccines
  • Peptide Antibiotics
  • Cytokines
  • Others

By Application

  • Pain
  • Infections
  • Autoimmune Diseases
  • Diabetes
  • Cardiovascular Diseases
  • Other

By Distribution Channel

  • Hospitals
  • Pharmacy
  • Ambulatory Surgical Centers
  • Others

Growth Drivers

  • Rising Prevalence of Diseases
  • Increasing Need for Vaccines amidst COVID-19 Pandemic


  • Long Time Taken for the Approval of Drugs

Healthcare Expenditure
Get more information on this report: Request Free Sample PDF

Top Featured Companies Dominating the Market

    • Sanofi-aventis Groupe
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • Bausch Health Companies Inc.
    • Boehringer Ingelheim International GmbH
    • AbbVie Inc.
    • Amgen Inc.
    • Novartis AG
    • Progenity, Inc.
    • Johnson & Johnson Services, Inc.


In The News

·  December 19, 2018: Pfizer Inc and GlaxoSmithKline plc announced to join hands to form new consumer healthcare joint venture, on a global level.

·  June 23, 2018: Amgen announced the launch of drug Repatha (evolocumab) that helps to significantly reduced cholesterol in Type 2 diabetes patients.

·  July 07, 2020: GlaxoSmithKline plc (GSK) and Medicago announced their collaboration to develop vaccine for COVID-19


Global Economic Impact

Request Insights
Despite Inflation & Fearing Recession, Businesses Across the Globe Expected to Do Better in 2023:

In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.

Author Credits:  Radhika Gupta, Shivam Bhutani

Key Questions Answered in the Report

1) What are the major factors driving the growth of the sterile injectable drugs market?

Ans: Rising government initiatives to curb spread of chronic diseases is one of the major factors driving the market growth.

2) What would be the CAGR of sterile injectable drugs market over the forecast period?

Ans: The market is anticipated to attain a considerable CAGR over the forecast period, i.e., 2021-2029.

3) What are the challenges affecting the sterile injectable drugs market growth?

Ans: Delay in drugs approval is one of the factors estimated to hamper the market growth.

4) Which region will provide more business opportunities for growth of sterile injectable drugs market in future?

Ans: The market in North America is estimated to garner the largest market share owing to the health awareness among people, high investment healthcare sector, and increasing R&D activities.

5) Who are the major players dominating the sterile injectable drugs market?

Ans: The major players in the market are GlaxoSmithKline plc, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, AbbVie Inc., Amgen Inc., Novartis AG, Progenity, Inc., Johnson & Johnson Services, Inc. and others.

6) How are the company profiles selected?

Ans: The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

7) What are the segments in the sterile injectable drugs market?

Ans: The market is segmented by type, drug class, application, distribution channel, and by region.

8) Which sub-segment captures the largest market size in the distribution channel segment in the market?

Ans: The hospitals segment is anticipated to hold largest market share over the forecast period on the back of the increasing patient pool, along with the easy availability and authenticity of the drugs.

Let Us Hear About Your Requirements:

Submit Your Request For Proposal (RFP)

 Request Free Sample Copy